Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘safety and clinical efficacy of bimekizumab in patients with active PsA who were bDMARD-naïve or TNFi-IR, and the second provided a comprehensive and updated overview of bimekizumab’s safety profile to support clinical decision-making.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The IMID Forum
Author Interview: Professor Valentino Paci, April 2026
Discussing RA: Updated EULAR recommendations and next-step strategies after TNF inhibitor failure
Author Interview: Professor Helena Marzo-Ortega, March 2026
Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions
Get summaries like this every morning.
Free AI-powered recaps of The IMID Forum and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.